BRUSSELS and AMSTERDAM, Nov. 4, 2026 /PRNewswire/ -- UCB, a global biopharmaceutical company, and Cradle, which builds a leading AI-driven protein design and engineering platform, today announced a strategic collaboration. The collaboration is the latest step in UCB's expanding digital antibody discovery and engineering program, which draws on the company's own successful antibody discovery platform combined with com
PR Newswire Business Technology ·